Related Experiment Video
Updated: Apr 26, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Patients are asking about e-cigarettes. What do we tell them?
D J Worsley1, K Jones2, Z Marshman1
1School of Clinical Dentistry, Claremont Crescent, Sheffield, S10 2TA;
E-cigarettes, electronic nicotine delivery systems, are increasingly popular. This article reviews their safety, efficacy, and regulatory status, offering guidance for health professionals and premises management.
Area of Science:
- Public Health
- Nicotine Addiction Research
- Consumer Product Safety
Background:
- E-cigarettes, electronic nicotine delivery systems (ENDS), emerged in 2004.
- The UK market for ENDS has seen rapid expansion.
- Public inquiries to health professionals regarding ENDS are frequent.
Purpose of the Study:
- To provide a comprehensive overview of e-cigarettes.
- To examine the evidence on the safety, quality, and efficacy of ENDS.
- To offer guidance for dental health professionals and premises management regarding ENDS use.
Main Methods:
- Literature review of existing research on e-cigarettes.
- Analysis of regulatory status and market trends in the UK.
- Synthesis of evidence regarding safety, quality, and efficacy.
- Development of practical advice for healthcare professionals.
Main Results:
- E-cigarettes deliver vaporized nicotine liquid.
- Evidence on the long-term safety, quality, and efficacy of ENDS is still developing.
- Regulatory frameworks for ENDS are evolving.
Conclusions:
- Health professionals require up-to-date information on e-cigarettes.
- Guidance is needed for advising patients and managing ENDS use in professional settings.
- Further research is essential to fully understand the implications of ENDS.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Inhaled Medications
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Asthma-IV: Nursing Management
First, in...